Document Detail

Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine.
MedLine Citation:
PMID:  22170564     Owner:  NLM     Status:  Publisher    
Δ(1)-Pyrroline-5-carboxylate synthetase (P5CS) catalyzes the first two steps of ornithine/proline biosynthesis. P5CS deficiency has been reported in three families, with patients presenting with cutis/joint laxity, cataracts, and neurodevelopmental delay. Only one family exhibited metabolic changes consistent with P5CS deficiency (low proline/ornithine/citrulline/arginine; fasting hyperammonemia). Here we report a new P5CS-deficient patient presenting the complete clinical/metabolic phenotype and carrying p.G93R and p.T299I substitutions in the γ-glutamyl kinase (γGK) component of P5CS. The effects of these substitutions are (1) tested in mutagenesis/functional studies with E.coli γGK, (2) rationalized by structural modelling, and (3) reflected in decreased P5CS protein in patient fibroblasts (shown by immunofluorescence). Using optical/electron microscopy on skin biopsy, we show collagen/elastin fiber alterations that may contribute to connective tissue laxity and are compatible with our angio-MRI finding of kinky brain vessels in the patient. MR spectroscopy revealed decreased brain creatine, which normalized after sustained arginine supplementation, with improvement of neurodevelopmental and metabolic parameters, suggesting a pathogenic role of brain creatine decrease and the value of arginine therapy. Morphological and functional studies of fibroblast mitochondria show that P5CS deficiency is not associated with the mitochondrial alterations observed in Δ(1)-pyrroline-5-carboxylate reductase deficiency (another proline biosynthesis defect presenting cutis laxa and neurological alterations).
Diego Martinelli; Johannes Häberle; Vicente Rubio; Cecilia Giunta; Ingrid Hausser; Rosalba Carrozzo; Nadine Gougeard; Clara Marco-Marín; Bianca M Goffredo; Maria Chiara Meschini; Elsa Bevivino; Sara Boenzi; Giovanna Stefania Colafati; Francesco Brancati; Matthias R Baumgartner; Carlo Dionisi-Vici
Related Documents :
9714504 - Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with re...
824124 - Clonazepam in the treatment of epilepsy. a clinical long-term follow-up study.
10869004 - Primarily chronic and cerebrovascular course of lyme neuroborreliosis: case reports and...
7208734 - A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, sev...
12233784 - Humoral galnac alpha1-3galnac-lipid reactivity of humans in hypomanic state.
21492424 - Combination of lung ultrasound (a comet-tail sign) and n-terminal pro-brain natriuretic...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-15
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  -     ISSN:  1573-2665     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Metabolism, Bambino Gesù Children's Hospital, Piazza Sant'Onofrio, 4, 00165, Rome, Italy,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Passivating ligand and solvent contributions to the electronic properties of semiconductor nanocryst...
Next Document:  Fluorescent Composite Hydrogels of Metal-Organic Frameworks and Functionalized Graphene Oxide.